Introduction

Many people who menstruate experience physical discomfort or emotional shifts in the days before their period. For a significant minority, those symptoms are severe enough to interfere with work, relationships, and daily routines. A London-based neurotechnology company is now offering a non-drug alternative: a wearable headband that delivers a mild electrical current to the scalp. The device has already been cleared in the United Kingdom and European Union for menstrual pain and premenstrual syndrome, and it recently received expanded authorization to address anxiety symptoms tied to premenstrual dysphoric disorder, a more intense form of PMS.

What Happened

Samphire Neuroscience announced on November 5 that its at-home transcranial direct current stimulation (tDCS) headband can now be used in the UK and EU to manage anxiety symptoms associated with PMDD. The company’s device, marketed as Nettle in Europe, applies a gentle current through four electrodes held against the scalp with saline-soaked sponges. Electrodes positioned near the forehead stimulate the dorsolateral prefrontal cortex, a region involved in mood regulation, while electrodes placed farther back target areas linked to pain processing.

The expanded clearance follows an independent study led by Paul Faulkner, a psychology researcher at Queen Mary University of London. Faulkner’s research involved 42 participants and used data from the Samphire headband to support the new indication. The findings have been submitted for peer review but have not yet been published. In the trial, users completed one 20-minute session daily for two weeks before their period. Participants reported a measurable reduction in anxiety symptoms after the first month, though the study did not find a clear difference in depressive symptoms compared with a placebo condition, a result Faulkner attributes partly to a strong placebo response.

Why This Matters

PMDD affects as many as one in ten women and is often described as a severe form of premenstrual syndrome. Anxiety and depression can spike in the premenstrual window, yet treatment options remain limited and frequently carry significant side effects. Current approaches generally rely on hormonal medication, antidepressants, or, in extreme cases, surgery. Because tDCS is noninvasive and does not require drugs or hormones, it represents a different kind of option for people who want to avoid pharmaceuticals.

The headband is designed for home use, which makes it more scalable than clinic-based brain stimulation methods such as transcranial magnetic stimulation. Samphire’s cofounder and CEO, Emilė Radytė, has said the company aims to address a long-standing gap in research that has often overlooked women’s health needs. The device is also sold under the name Lutea in regions where it is classified as a wellness product rather than a regulated medical device, though labeling and pricing vary by location.

Key Takeaways

  • Samphire Neuroscience’s tDCS headband is cleared in the UK and EU for menstrual pain, PMS, and now PMDD-related anxiety.
  • The device uses four scalp electrodes to stimulate brain regions associated with mood and pain regulation.
  • Users typically complete short daily sessions in the weeks leading up to menstruation, guided by a mobile app.
  • An independent study with 42 participants supported the anxiety indication, though results are still awaiting peer-reviewed publication.
  • Minor electrode burns are the most commonly reported side effect, which researchers describe as less disruptive than many medication side effects.
  • In the United States, the same technology is sold as a wellness device called Lutea, not as a prescription medical treatment.

Conclusion

The European authorization marks a notable step for neurotechnology in women’s health, offering a drug-free path for managing premenstrual anxiety and pain. Still, questions remain about insurance coverage, long-term outcomes, and which patients are most likely to benefit. Samphire plans to explore additional applications, including endometriosis-related pain, while researchers continue to refine the protocol. For now, the headband provides a new tool for people seeking alternatives to hormones and antidepressants, though consumers should pay close attention to how the product is labeled and regulated in their own country.